Mill Creek Capital Advisors »

Biosante Pharmaceuticals shares owned by Mill Creek Capital Advisors

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Mill Creek Capital Advisors from 13F filings

Historical chart of Mill Creek Capital Advisors investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Mill Creek Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Mill Creek Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $213k 2.7k 78.94

More positions owned by Mill Creek Capital Advisors

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core Msci Total (IXUS)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Us Treas Bd Etf (GOVT)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Sml Cp Grw Etf (VBK)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Mbs Etf (MBB)
Vanguard Scottsdale Fds Total Corp Bnd (VTC)
Lattice Strategies Tr Hartford Mlt Etf (RODM)
Ishares Tr Msci Acwi Etf (ACWI)

View all positions for Mill Creek Capital Advisors

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
State Street Corporation
Citadel Advisors
Global Alpha Capital Management
Dimensional Fund Advisors
Soleus Capital Management
Tang Capital Management
Deep Track Capital
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Deutsche Bank Aktiengesellschaft
Nuveen
Ranger Investment Management

View all funds holding Biosante Pharmaceuticals